Enable Block: 

The global Ebola infection tally has surpassed 15,000. Sierra Leone confirmed 533 new cases in the week to November 16, accounting for much of the increase.

Friday, the UN health agency had reported 5,177 deaths and 14,413 cases

The government today formed a three-member committee to inspect Ebola virus preparedness efforts at airports.

Ebola has substantially impacted all sectors of employment in the Liberian economy, in both affected and non-affected counties, according to the most recent round of mobile phone surveys conducted

The Ebola virus disease that has caused a medical emergency in the three-most affected countries in West Africa is also affecting the means of making a living of millions of the poorest and most vu

The European Union is continuing to scale up its response to the Ebola epidemic as its Coordinator for the emergency, Commissioner Christos Stylianides together with Vytenis Andriukaitis, Commissio

n mid-October 2014, the number of cases of the West Africa Ebola virus epidemic in Guinea, Sierra Leone and Liberia exceeded 9,000 cases. The early growth dynamics of the epidemic has been qualitatively different for each of the three countries. However, it is important to understand these disparate dynamics as trends of a single epidemic spread over regions with similar geographic and cultural aspects, with likely common parameters for transmission rates and reproduction number R0.

Several monoclonal antibodies (mAb) are being evaluated as treatment options for the current 2014 Ebola outbreak. But they were derived from and tested for protection against the older 1976 Mayinga or 1995 Kikwit Zaire Ebolaviruses (EBOV). The EBOV sequences reported for the current outbreak contain several mutations whose significance remained to be established.

SAN JUAN: The rapid propagation in recent years of infectious diseases such as Malaria, Chikungunya and even Ebola is one more example of how climate change threatens global health security.

In the race to develop an Ebola vaccine, a small cancer therapy company, NewLink Genetics, has been in the shadows of GlaxoSmithKline (GSK), a big pharma company with lots of experience and far deeper resources. But at a high-level meeting held by the World Health Organization on 23 October, it became clear that NewLink, which is based in Ames, Iowa, by next spring may have more vaccine on hand than GSK, which is based in the United Kingdom. NewLink's projections come with a major caveat: It all depends on dose.